
8-K
1
tm19246101_8k.htm
FORM 8-K



     





 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): December
5, 2019 (December 2, 2019)

 

LONGEVITY ACQUISITION CORPORATION

(Exact name of registrant as specified in
its charter)

 



    British Virgin Islands
    001-38637
    N/A

    (State or other jurisdiction
of incorporation)
    (Commission
File Number)
    (IRS Employer
Identification No.)

 

Yongda International Tower No. 2277

Longyang Road, Pudong District, Shanghai

People’s Republic of China

(Address of principal executive offices,
including zip code)

 

Registrant’s telephone number, including
area code: (86) 21-60832028

 

Not Applicable
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 



    ¨
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     
     

    ¨
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     
     

    ¨
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     
     

    ¨
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered
pursuant to Section 12(b) of the Act:

 





    Title of each class
     
    Trading Symbol(s)
     
    Name of each exchange on which registered

    Ordinary shares, no par value
     
    LOAC
     
     The NASDAQ Stock Market LLC

    Warrants to purchase one-half of one ordinary share
     
    LOACW
     
    The NASDAQ Stock Market LLC

    Rights to receive one-tenth (1/10) of one ordinary share
     
    LOACR
     
    The NASDAQ Stock Market LLC

    Units, each consisting of one ordinary share, one right and one warrant
     
    LOACU
     
    The NASDAQ Stock Market LLC











 

Indicate by check mark
whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this
chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging
growth company  x

 

If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 



     
     
    

  



    
    Item 5.02.
    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


On December 2, 2019, Minguang Wang resigned as a Class I director of Longevity Acquisition Corporation (the “Company”)
to pursue other professional interests.

 

On December 2, 2019, the board of directors (the “Board”)
of the Company appointed Pai Liu as a Class I director to serve until the 2019 annual meeting of stockholders of the Company. Mr.
Liu has also been appointed to serve as a member of the audit committee of the Board and as the chairman of the compensation committee
of the Board.

 

Pai Liu has served as chief executive officer of Wuhan
Dacheng Equity Investment Fund Management Company since July 2016. From December 2014 to April 2016, Mr. Liu was a senior
associate of Deloitte in China. From September 2013 to October 2014, Mr. Liu served as a senior associate of Mazars Group in
China. From October 2011 to September 2013, Mr. Liu served as an associate of PricewaterhouseCoopers in its Shanghai office
and was involved in the auditing of large and medium-sized foreign enterprises. Mr. Liu earned his Master’s degree in
accounting & finance from Leeds University in the United Kingdom and received a bachelor’s degree in finance from
the South Central University for Nationalities in China.

  

There were no arrangements or understandings between Mr. Liu
and any other persons pursuant to which Mr. Liu was appointed as a director of the Company. In addition, there are no family relationships
between Mr. Liu and any director, executive officer, or person nominated or chosen by the Company to become a director or executive
officer. Furthermore, since the inception of the Company, there have been no transactions in which the Company was or is to be
a participant and the amount involved exceeds $120,000, and in which Mr. Liu had or will have a direct or indirect material interest,
and there are currently no such proposed transactions.

  



     
     
    

  

SIGNATURE

  

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.

 



     
    LONGEVITY ACQUISITION CORPORATION
     

     
     
     
     

    Date: December 5, 2019
    By:
    /s/ Matthew Chen 
     

     
     
    Name: Matthew Chen
     

     
     
    Title: Chairman and Chief Executive Officer
     

 

 



 


     
    






